CalciMedica, Inc.
CALC
$0.74
-$0.08-10.32%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -45.41% | -19.32% | 8.31% | -19.48% | 52.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.95% | -2.06% | 1.41% | 12.66% | 42.90% |
| Operating Income | 28.95% | 2.06% | -1.41% | -12.66% | -42.90% |
| Income Before Tax | -152.70% | -38.91% | -50.63% | -3,978.46% | -2.70% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -152.70% | -38.91% | -50.63% | -3,978.46% | -2.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -152.70% | -38.91% | -50.63% | -3,978.46% | -2.70% |
| EBIT | 28.95% | 2.06% | -1.41% | -12.66% | -42.90% |
| EBITDA | 28.87% | 2.01% | -1.41% | -12.69% | -43.21% |
| EPS Basic | -106.76% | -2.60% | -11.79% | -2,784.21% | 54.53% |
| Normalized Basic EPS | -106.77% | -2.60% | -11.75% | -2,789.16% | 54.53% |
| EPS Diluted | -106.76% | -2.60% | -11.79% | -3,700.00% | 54.53% |
| Normalized Diluted EPS | -106.77% | -2.60% | -11.75% | -2,855.56% | 54.53% |
| Average Basic Shares Outstanding | 22.23% | 35.40% | 34.74% | 44.77% | 125.81% |
| Average Diluted Shares Outstanding | 22.23% | 35.40% | 34.74% | 40.55% | 125.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |